Revolutionizing Egg Quality Research for Fertility Success

Aria Fertility’s groundbreaking study on NMN’s role in improving egg quality, combining animal and human data, was presented at ESHRE 2025. The research explores NAD+ metabolism’s impact on mitochondrial function and oxidative stress in eggs, offering potential benefits for older patients. Collaborated with UCL, this translational approach addresses variability in egg quality, a critical factor in fertility success.

Key Takeaways

NMN’s Potential in Enhancing Egg Quality for Older Patients

NAD+ metabolism via NMN supplementation shows promise in restoring mitochondrial function and reducing oxidative stress in eggs. This could improve egg quality variability, particularly in older patients, by targeting age-related mitochondrial decline. Human transcriptomic analysis confirms these mechanisms align with animal model findings.

Translational Research Combining Animal and Human Data

Aria’s collaboration with UCL uniquely integrates systematic animal model reviews with real-world human transcriptomic data. This dual approach accelerates scientific validation of NMN’s efficacy, bridging laboratory discoveries with clinical applications in fertility treatment.

AI Integration in Fertility Labs for Faster, Safer Outcomes

The lab is prioritizing AI-driven innovations to streamline embryo assessment and reduce time to pregnancy. By leveraging machine learning for non-invasive analysis, they aim to maintain safety standards while improving treatment efficiency for patients.

Ethical Innovation Through Diverse Institutional Review Boards

Aria’s dedicated IRB includes scientists, ethicists, and community representatives to ensure ethical compliance. This multidisciplinary oversight guarantees patient safety, informed consent, and social responsibility in all emerging fertility technologies.

IVM Strategies to Reduce Ovarian Stimulation Risks

Research into in vitro maturation (IVM) focuses on non-invasive egg development outside the body. This approach minimizes risks associated with ovarian stimulation, offering safer alternatives for patients undergoing fertility treatments.

Source: Read full article